NCT04676594View on ClinicalTrials.gov

Genentech Validation Tool for Pulmonary Fibrosis

RecruitingOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

October 4, 2020

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions

Interstitial Lung Disease

Trial Locations (1)

10032

RECRUITING

Columbia University Irving Medical Center, New York

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Columbia University

OTHER

NCT04676594 - Genentech Validation Tool for Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter